BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Aclaris Therapeutics Raises $21 Million in Stock Sale


9/13/2012 9:10:14 AM

Philadelphia Business Journal by John George, Senior Reporter

Aclaris Therapeutics raised $20.9 million in private stock sale this week, according to documents filed with the Securities and Exchange Commission.

The biopharmaceutical company, based in Malvern, Pa., is specializing in developing new treatments for skin disorders.

Philadelphia law firm Duane Morris served as financial adviser to Aclaris for the company’s series A venture capital financing. The identity of the investors was not disclosed.

Aclaris, established earlier this year, is led by President and CEO Neal Walker who was previously the chief executive of another local biopharmaceutical company, Vicept, which was acquired by Allergan last year in a deal valued at up to $275 million.



 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->